Shingles vaccine may provide protection after 10 years: Study | Lifestyle Health | English Manorama – Onmanorama

In a breakthrough study featured in the BMJ, a general medical journal that publishes open-access titles, the live zoster (shingles) vaccine takes centre stage in the quest for sustained wellness. Revealing its peak effectiveness in the initial year post-vaccination, this research unravels a compelling narrative of enduring protection against shingles and its complications, even after a decade, especially for those with weakened immune systems.

Insights for Healthy Living: When does the live zoster vaccine offer its prime defence? Discover the vaccine's peak efficacy within the first year, aligning with your journey towards a healthier lifestyle. How does the vaccine's effectiveness evolve over the years? Uncover the vaccine's journey, from a 67% shield against herpes zoster infection to a resilient 15% protection after ten years.

Can the live zoster vaccine be your long-term ally? Delve into the study's revelations, showcasing the vaccine's lasting protection against complications like post-herpetic neuralgia and hospitalisation for herpes zoster.

Navigating Wellness: Highlight: Embark on a wellness expedition with insights from the Kaiser Permanente study, involving 1.5 million adults aged 50, providing a roadmap for sustained health.

Timeline of Effectiveness: Initial-year efficacy: A robust 67% defence against herpes zoster infection. Ongoing journey: Witness the vaccine's resilience, from a 50% stronghold in the second year to a commendable 27% in the eighth year.

Guardianship Against Complications: For post-herpetic neuralgia, the vaccine maintains a reassuring 41% efficacy after a decade. Journeying from 5-8 years post-vaccination, hospitalisation for herpes zoster still sees a commendable 53% efficacy.

(With inputs from IANS)

Read more from the original source:

Shingles vaccine may provide protection after 10 years: Study | Lifestyle Health | English Manorama - Onmanorama